PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Brighton and Sussex University Hospitals NHS Trust, Brighton, UK alyss.robinson@nhs.net.\', \'Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.\', \'Brighton and Sussex Medical School, University of Sussex, Brighton, UK, and consultant in intensive care medicine, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.\', \'Brighton and Sussex Medical School, University of Sussex, Brighton, UK, and consultant in infectious disease, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.\', \'Western Sussex Hospitals NHS Foundation Trust, Worthing, UK.\', \'Brighton and Sussex Medical School, University of Sussex, Brighton, UK, and consultant in haematology, Brighton and Sussex University Hospitals NHS Trust, Brighton, UK.\']
?:citedBy
  • -1
?:creator
?:doi
?:doi
  • 10.7861/clinmed.2020.1007
?:hasPublicationType
?:journal
  • Clinical medicine (London, England)
is ?:pmid of
?:pmid
?:pmid
  • 33727368
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • -1.0
?:rankingScore_hIndex
  • -1
is ?:relation_isRelatedTo_publication of
?:title
  • Real-world experience of SARS-CoV-2 antibody assays in UK healthcare workers.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all